News and Updates

The FDA has authorized a new Parkinson’s disease clinical trial. Learn about this potential disease-modifying therapy and what it means for neuro research.

Can biomarkers predict depression treatment success? Discover how a new precision medicine trial using bupropion and sertraline is changing psychiatry.

A new clinical trial explores innovative treatments for heart failure, aiming to improve patient outcomes and reshape standard cardiac care protocols.

Explore the latest Phase III SENTRY trial results for selinexor. Discover how this XPO1 inhibitor is shaping the future of targeted oncology treatments.

Discover how AI is revolutionizing biologics manufacturing, optimizing bioprocessing, and accelerating drug development timelines in modern CDMO workflows.

EU regulators have reversed their approval recommendation for Tavneos (avacopan). Discover what this setback means for the ANCA-associated vasculitis drug.

Discover how new EpiCrispr gene silencing technology is transforming muscular dystrophy treatment by promoting muscle growth without altering DNA.

New research shows ChatGPT-5 provides overly optimistic projections for macular hole surgery, highlighting critical risks in relying on AI for medical advice.

The US is rolling out a new experimental Ebola drug to boost outbreak response. Discover how this antiviral treatment aims to improve patient survival.

A historic CAR-T approval for solid tumors and a $10B Pfizer-Innovent pact signal a new era of global oncology innovation and strategic biopharma growth.